Search results
AstraZeneca (LON:AZN) Earns “Buy” Rating from Shore Capital
ETF DAILY NEWS· 1 day agoShore Capital reissued their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report published on Tuesday morning, Marketbeat Ratings reports ...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 4 days agoThe Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai,...
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
Zacks via Yahoo Finance· 4 days agoAstraZeneca AZN announced its long-term plan to generate $80 billion in total revenues by 2030,...
AstraZeneca aims for $80 billion in total revenue by 2030 By Reuters
Investing.com· 4 days agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier...
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Kingsview Wealth Management LLC
ETF DAILY NEWS· 3 days agoKingsview Wealth Management LLC grew its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 11.3% during the 4th quarter, according to the company in its most recent disclosure ...
AstraZeneca aims for $80 billion in total revenue by 2030
Reuters via Yahoo News· 4 days agoAstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday, boosted by...
AstraZeneca to establish $1.5bn ADC production site in Singapore
Pharmaceutical Technology via Yahoo Finance· 4 days agoAstraZeneca is set to invest $1.5bn in a new manufacturing facility in Singapore dedicated to...
AstraZeneca kicks off 'new era of growth' with aim to hit $80 billion of sales by 2030
Morningstar· 4 days agoAstraZeneca on Tuesday outlined ambitions to almost double its sales over the next six years by launching 20 new medicines by 2030. In a statement, the Anglo-Swedish pharmaceutical ...
European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target
Investing.com· 4 days agoEuropean stocks fall in Fed rate concerns; AstraZeneca lifts revenue target
AstraZeneca aims to deliver $80 billion in total revenue by 2030
KFGO· 4 days ago(Reuters) -AstraZeneca said on Tuesday it expects to deliver $80 billion in total revenue by 2030,...